Differential regulation of interleukin-12 (IL-12), tumor necrosis factor alpha, and IL-1 beta production in human myeloid leukemia cell lines and peripheral blood mononuclear cells - PubMed (original) (raw)
. 1994 Apr 1;83(7):1847-55.
Affiliations
- PMID: 7908232
Free article
Differential regulation of interleukin-12 (IL-12), tumor necrosis factor alpha, and IL-1 beta production in human myeloid leukemia cell lines and peripheral blood mononuclear cells
M Kubin et al. Blood. 1994.
Free article
Abstract
Natural killer cell-stimulatory factor or interleukin-12 (NKSF/IL-12) was originally identified and purified from the conditioned medium of Epstein-Barr virus (EBV)-transformed B-cell lines. Phorbol diesters were observed to be potent stimulators of NKSF/IL-12 production from the B-cell lines. Although monocytes were found to be the major producers of NKSF/IL-12 in peripheral blood (PB) in response to lipopolysaccharide (LPS) or to Staphylococcus aureus, several myeloid leukemia cell lines tested did not produce detectable NKSF/IL-12 either constitutively or upon stimulation with phorbol diesters. However, three lines, ML-3, HL-60, and THP-1, responded to LPS with significant levels of NKSF/IL-12 production, whereas S aureus was effective only on THP-1 cells. When the cell lines were preincubated with compounds known to induce them to differentiate, production of tumor necrosis factor alpha (TNF alpha) and IL-1 beta was in most cases maximal in cells with differentiated characteristics, whereas NKSF/IL-12 production in response to LPS in all three producing cell lines was significantly enhanced only by pretreatment with dimethylsulfoxide (DMSO) for 24 hours, or by costimulation with interferon gamma (IFN gamma). The efficiency of DMSO enhancement of NKSF/IL-12 production decreased after 2 to 5 days of incubation, when the cells acquired differentiated characteristics. Unlike DMSO, IFN gamma enhanced NKSF/IL-12 production, and IL-10 and dexamethasone inhibited it in cell lines and PB mononuclear cells stimulated by either LPS or S aureus. The ability of the cell lines to respond to these mediators of possibly physiologically relevant function provides a tissue-culture model for studying their mechanism of action.
Similar articles
- Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.
D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E, et al. D'Andrea A, et al. J Exp Med. 1992 Nov 1;176(5):1387-98. doi: 10.1084/jem.176.5.1387. J Exp Med. 1992. PMID: 1357073 Free PMC article. - Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. D'Andrea A, et al. J Exp Med. 1993 Sep 1;178(3):1041-8. doi: 10.1084/jem.178.3.1041. J Exp Med. 1993. PMID: 8102388 Free PMC article. - Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation.
Trinchieri G, Wysocka M, D'Andrea A, Rengaraju M, Aste-Amezaga M, Kubin M, Valiante NM, Chehimi J. Trinchieri G, et al. Prog Growth Factor Res. 1992;4(4):355-68. doi: 10.1016/0955-2235(92)90016-b. Prog Growth Factor Res. 1992. PMID: 1364096 Review. - Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.
Chehimi J, Valiante NM, D'Andrea A, Rengaraju M, Rosado Z, Kobayashi M, Perussia B, Wolf SF, Starr SE, Trinchieri G. Chehimi J, et al. Eur J Immunol. 1993 Aug;23(8):1826-30. doi: 10.1002/eji.1830230814. Eur J Immunol. 1993. PMID: 8102101 - [Function and molecular structure of IL-12].
Oshimi K, Hoshino S. Oshimi K, et al. Nihon Rinsho. 1992 Aug;50(8):1840-4. Nihon Rinsho. 1992. PMID: 1359171 Review. Japanese.
Cited by
- CD40 Signaling in Mice Elicits a Broad Antiviral Response Early during Acute Infection with RNA Viruses.
Rogers KJ, Richards PT, Zacharias ZR, Stunz LL, Vijay R, Butler NS, Legge KL, Bishop GA, Maury W. Rogers KJ, et al. Viruses. 2023 Jun 12;15(6):1353. doi: 10.3390/v15061353. Viruses. 2023. PMID: 37376652 Free PMC article. - New models of lipopolysaccharide-induced implantation loss reveal insights into the inflammatory response.
Moustafa S, Joseph DN, Taylor RN, Whirledge S. Moustafa S, et al. Am J Reprod Immunol. 2019 Feb;81(2):e13082. doi: 10.1111/aji.13082. Epub 2019 Jan 28. Am J Reprod Immunol. 2019. PMID: 30604526 Free PMC article. - Differential expression profiling of spleen microRNAs in response to two distinct type II interferons in Tetraodon nigroviridis.
Yi S, Lu D, Peng W, Wang T, Zhang Y, Lin H. Yi S, et al. PLoS One. 2014 May 6;9(5):e96336. doi: 10.1371/journal.pone.0096336. eCollection 2014. PLoS One. 2014. PMID: 24800866 Free PMC article. - Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies.
Inoue N, Watanabe M, Yamada H, Takemura K, Hayashi F, Yamakawa N, Akahane M, Shimizuishi Y, Hidaka Y, Iwatani Y. Inoue N, et al. J Clin Immunol. 2012 Dec;32(6):1243-52. doi: 10.1007/s10875-012-9721-0. Epub 2012 Jun 17. J Clin Immunol. 2012. PMID: 22706687 - Interleukin 6 and 12, alanine aminotransferase activity, and HCV viral load in children with chronic hepatitis C treated with interferon and ribavirin.
Kowala-Piaskowska A, Mozer-Lisewska I, Figlerowicz M, Machowska L, Słuzewski W. Kowala-Piaskowska A, et al. Inflammation. 2004 Dec;28(6):319-25. doi: 10.1007/s10753-004-6642-y. Inflammation. 2004. PMID: 16245074